Patents by Inventor Adrián RODRÍGUEZ RODRÍGUEZ

Adrián RODRÍGUEZ RODRÍGUEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11213535
    Abstract: The present invention is related to a composition comprising phytic acid or a phytate salt, magnesium in the form of salt, hydroxide or oxide and optionally at least one polyphenol. These components may be in isolated form or be part of an enriched plant extract. The invention is also related to the use of this composition for the treatment of renal lithiasis, preferably calcium or calcium oxalate lithiasis, either in the form of a medicament, a nutraceutical or functional food or food supplement.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: January 4, 2022
    Assignee: UNIVERSITAT DE LES ILLES BALEARS
    Inventors: Félix Grases Freixedas, Antonia Costa Bauzá, Rafael María Prieto Almirall, Adrián Rodríguez Rodríguez
  • Patent number: 11207365
    Abstract: The present invention is related to the use of a separate, sequential or simultaneous combination of at least one urinary acidifier with at least one calcium phosphate crystallization inhibitor for urine acidification, and thus preventing the pH at which supersaturation of calcium phosphate is produced and consequently, renal lithiasis.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: December 28, 2021
    Assignee: UNIVERSITAT DE LES ILLES BALEARS
    Inventors: Félix Grases Freixedas, Antonia Costa Bauzá, Rafael María Prieto Almirall, Adrián Rodríguez Rodríguez
  • Publication number: 20190216873
    Abstract: The present invention is related to the use of a separate, sequential or simultaneous combination of at least one urinary acidifier with at least one calcium phosphate crystallization inhibitor for urine acidification, and thus preventing the pH at which supersaturation of calcium phosphate is produced and consequently, renal lithiasis.
    Type: Application
    Filed: January 25, 2019
    Publication date: July 18, 2019
    Inventors: Félix GRASES FREIXEDAS, Antonia COSTA BAUZÁ, Rafael María PRIETO ALMIRALL, Adrián RODRÍGUEZ RODRÍGUEZ
  • Patent number: 10149851
    Abstract: The present invention refers to the use of theobromine or its derivatives as an inhibitor of the crystallization of uric acid to avoid the formation of uric acid crystals in urine and as a consequence renal lithiasis or specifically uric acid renal lithiasis.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: December 11, 2018
    Assignee: UNIVERSITAT DE LES ILLES BALEARS
    Inventors: Félix Grases Freixedas, Antonia Costa Bauzá, Rafael María Prieto Almirall, Adrián Rodríguez Rodríguez
  • Publication number: 20170143724
    Abstract: The present invention refers to the use of theobromine or its derivatives as an inhibitor of the crystallisation of uric acid to avoid the formation of uric acid crystals in urine and as a consequence renal lithiasis or specifically uric acid renal lithiasis.
    Type: Application
    Filed: April 15, 2015
    Publication date: May 25, 2017
    Inventors: Félix GRASES FREIXEDAS, Antonia COSTA BAUZÁ, Rafael María PRIETO ALMIRALL, Adrián RODRÍGUEZ RODRÍGUEZ
  • Publication number: 20170128469
    Abstract: The present invention is related to a composition comprising phytic acid or a phytate salt, magnesium in the form of salt, hydroxide or oxide and optionally at least one polyphenol. These components may be in isolated form or be part of an enriched plant extract. The invention is also related to the use of this composition for the treatment of renal lithiasis, preferably calcium or calcium oxalate lithiasis, either in the form of a medicament, a nutraceutical or functional food or food supplement.
    Type: Application
    Filed: April 14, 2015
    Publication date: May 11, 2017
    Applicant: UNIVERSITAT DE LES ILLES BALEARS
    Inventors: Félix GRASES FREIXEDAS, Antonia COSTA BAUZÁ, Rafael María PRIETO ALMIRALL, Adrián RODRÍGUEZ RODRÍGUEZ
  • Publication number: 20170106032
    Abstract: The present invention is related to the use of a separate, sequential or simultaneous combination of at least one urinary acidifier with at least one calcium phosphate crystallization inhibitor for urine acidification, and thus preventing the pH at which supersaturation of calcium phosphate is produced and consequently, renal lithiasis.
    Type: Application
    Filed: March 31, 2015
    Publication date: April 20, 2017
    Inventors: Félix GRASES FREIXEDAS, Antonia COSTA BAUZÁ, Rafael María PRIETO ALMIRALL, Adrián RODRÍGUEZ RODRÍGUEZ